William Lis, Chief Executive Officer at PORTOLA PHARMACEUTICALS INC (PTLA), sold 40,000 shares at $27.17 ($1.1M) on 2014-11-20, disclosed to the SEC on 2014-11-20.
Scheduled sale ($1.1M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.32 | 10,000 | $273K | 25.3% |
| 2 | $26.68 | 15,000 | $400K | 37.1% |
| 3 | $26.98 | 14,800 | $399K | 37.0% |
| 4 | $27.17 | 200 | $5K | 0.5% |
| Total | $26.95 avg | 40,000 | $1.1M | 100% |
| Filing → |
| ZLAB | SELL | 2025-06-23 | $985K | — | Filing → |
| ZLAB | SELL | 2025-03-04 | $989K | — | Filing → |
| ZLAB | SELL | 2024-07-03 | $358K | — | Filing → |